Use of Sugammadex at the End of Case in Routine Anesthesia (MK-8616-023)
Clinical trial NCT00298831 · COMPLETED
Trial details
- NCT number
- NCT00298831
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-10-27
- Primary completion
- 2006-05-22
- Enrollment
- 224
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.